Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.
about
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN® (dendritic cell-based vaccine): a case report.
P2860
Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune-related Adverse Events ...... III and IV Melanoma Patients.
@en
type
label
Immune-related Adverse Events ...... III and IV Melanoma Patients.
@en
prefLabel
Immune-related Adverse Events ...... III and IV Melanoma Patients.
@en
P2093
P2860
P1476
Immune-related Adverse Events ...... e III and IV Melanoma Patients
@en
P2093
Carl G Figdor
Cornelis J A Punt
Erik H J G Aarntzen
Gerty Schreibelt
Harm Westdorp
Jeroen H A Creemers
Rutger H T Koornstra
Steve Boudewijns
Winald R Gerritsen
P2860
P304
P356
10.1097/CJI.0000000000000127
P577
2016-07-01T00:00:00Z